Last 13,950 KRW
Change Today -50.00 / -0.36%
Volume 265.8K
054670 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 10:49 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

daehan new pharm co ltd (054670) Snapshot

Open
14,200
Previous Close
14,000
Day High
14,400
Day Low
13,800
52 Week High
09/2/14 - 42,100
52 Week Low
02/20/14 - 5,810
Market Cap
200.3B
Average Volume 10 Days
1.2M
EPS TTM
-139.00
Shares Outstanding
14.4M
EX-Date
12/29/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DAEHAN NEW PHARM CO LTD (054670)

Related News

No related news articles were found.

daehan new pharm co ltd (054670) Related Businessweek News

No Related Businessweek News Found

daehan new pharm co ltd (054670) Details

Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and animal health products primarily in South Korea. The company offers hepatic protectors, osteoporosis, urinary reproductive substances, digestive substances, mental nerve substances, respiratory substances, infections therapeutics, muscle relaxants, circulatory substances, antispasmodics, antihistamines, and antipyretic analgesic and anti-inflammatory products; and products for the treatment of diabetes and obesity. It also provides animal health products, including metabolic stimulants, disinfectants, antibiotic antimicrobial products, coccidiosis repellents, and bot gujeje products. In addition, the company offers herbals, health foods, and functional beverages. It exports anticancer drugs, antibiotics, thrombolytics, vasodilators, antihistamins, and antidiabetics primarily to Southeast Asia, Latin America, and Africa; and supplies animal feed to Pakistan. The company offers its products in various forms comprising tablets, capsules, granules, powder, creams, ointments, gels, unguents, vials, and ampoules. Daehan New Pharm Co., Ltd. was founded in 1984 and is based in Hwaseong, South Korea.

daehan new pharm co ltd (054670) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

daehan new pharm co ltd (054670) Key Developments

Daehan New Pharm Co., Ltd., Annual General Meeting, Mar 21, 2014

Daehan New Pharm Co., Ltd., Annual General Meeting, Mar 21, 2014., at 09:00 Korea Standard Time. Location: Conference Room, Hyangnam Pharmaceutical Corporation. Agenda: To consider financial statements for the year ended December 31, 2013; to consider the amendment of the case; to consider to change the company's reason for existence or dissolution period; to consider the election of Directors; to approve director remuneration; and to consider the approval of the remuneration.

Daehan New Pharm Co., Ltd. Proposes Articles of Incorporation

Daehan New Pharm Co., Ltd. proposed articles of incorporation to change the tenure of the director at the AGM to be held on Mar. 22, 2013.

Daehan New Pharm Co., Ltd., Annual General Meeting, Mar 22, 2013

Daehan New Pharm Co., Ltd., Annual General Meeting, Mar 22, 2013., at 09:00 Korea Standard Time. Location: Hyangnam Pharmaceutical Industrial Complex Large Conference Room. Agenda: To consider sales reports, audit reports; to approve statements of appropriation of retained earnings and financial statements; to consider articles of incorporation to change for the purpose of the tenure of director; to consider appointment of outside directors; to approve directors' remuneration limit; and to approve the audit fees limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
054670:KS 13,950.00 KRW -50.00

054670 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 054670.
View Industry Companies
 

Industry Analysis

054670

Industry Average

Valuation 054670 Industry Range
Price/Earnings 100.0x
Price/Sales 2.8x
Price/Book 2.5x
Price/Cash Flow 161.0x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEHAN NEW PHARM CO LTD, please visit www.dhnp.co.kr/eng/default.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.